Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022387145> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2022387145 endingPage "1016" @default.
- W2022387145 startingPage "1012" @default.
- W2022387145 abstract "The assessment of reversibility is recognized as being an essential part of the management of airways obstruction, but testing for reversibility of airways obstruction may not be useful for identifying patients with chronic obstructive pulmonary disease (COPD) who are likely to benefit from bronchodilator treatment. We studied 100 patients with stable COPD. Early reversibility of airways obstruction to 200 mg salbutamol and peak bronchodilation to 50 micrograms salmeterol or 200 micrograms salbutamol were evaluated in four different sessions (two for salbutamol and two for salmeterol), using a double-blind, cross-over, randomized study. Fifteen minutes after inhalation of salbutamol, 47 patients presented an increase in FEV1 greater than 15% of baseline, whereas 48 showed an increase of FEV1 of at least 160 ml from basal value and 33 an increase in FEV1 greater than both 15% of baseline and 200 ml. On the contrary, 69 patients presented an increase in FEV1 greater than 15% of baseline, 65 an increase of FEV1 of at least 160 ml from basal value and 60 an increase in FEV1 greater than both 15% of baseline and 200 ml as maximum increase over baseline usually 2-4 h after inhalation of salmeterol. Twenty-seven other subjects defined as irreversible by the lack of acute improvement in FEV1 after salbutamol, showed an increase in FEV1 greater than 15% of baseline, 20 showed an increase of FEV1 of at least 160 ml from basal value, and 18 showed an increase in FEV1 greater than both 15% of baseline and 200 ml; all had the maximum degree of bronchodilation usually 1-2 h after salbutamol administration. These findings clearly demonstrate that many patients suffering from stable COPD show early reversibility to a short-acting beta 2-agonist and patients who do not manifest early reversibility to salbutamol can still benefit from salbutamol or salmeterol. Therefore, treatments with beta 2-agonists must always be tried." @default.
- W2022387145 created "2016-06-24" @default.
- W2022387145 creator A5038843499 @default.
- W2022387145 creator A5060089859 @default.
- W2022387145 creator A5062907116 @default.
- W2022387145 creator A5067697430 @default.
- W2022387145 date "1998-08-01" @default.
- W2022387145 modified "2023-09-26" @default.
- W2022387145 title "Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease" @default.
- W2022387145 cites W1892949664 @default.
- W2022387145 cites W2049916892 @default.
- W2022387145 cites W2094107830 @default.
- W2022387145 cites W2108401555 @default.
- W2022387145 cites W2139659037 @default.
- W2022387145 cites W4230551909 @default.
- W2022387145 cites W4236639597 @default.
- W2022387145 cites W4244598283 @default.
- W2022387145 doi "https://doi.org/10.1016/s0954-6111(98)90347-x" @default.
- W2022387145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9893768" @default.
- W2022387145 hasPublicationYear "1998" @default.
- W2022387145 type Work @default.
- W2022387145 sameAs 2022387145 @default.
- W2022387145 citedByCount "29" @default.
- W2022387145 countsByYear W20223871452012 @default.
- W2022387145 crossrefType "journal-article" @default.
- W2022387145 hasAuthorship W2022387145A5038843499 @default.
- W2022387145 hasAuthorship W2022387145A5060089859 @default.
- W2022387145 hasAuthorship W2022387145A5062907116 @default.
- W2022387145 hasAuthorship W2022387145A5067697430 @default.
- W2022387145 hasBestOaLocation W20223871451 @default.
- W2022387145 hasConcept C126322002 @default.
- W2022387145 hasConcept C2776042228 @default.
- W2022387145 hasConcept C2776178081 @default.
- W2022387145 hasConcept C2776719499 @default.
- W2022387145 hasConcept C2776780178 @default.
- W2022387145 hasConcept C2776954882 @default.
- W2022387145 hasConcept C2777394947 @default.
- W2022387145 hasConcept C2777714996 @default.
- W2022387145 hasConcept C2778024521 @default.
- W2022387145 hasConcept C2779306644 @default.
- W2022387145 hasConcept C2781018748 @default.
- W2022387145 hasConcept C2908646376 @default.
- W2022387145 hasConcept C2909548125 @default.
- W2022387145 hasConcept C42219234 @default.
- W2022387145 hasConcept C71924100 @default.
- W2022387145 hasConceptScore W2022387145C126322002 @default.
- W2022387145 hasConceptScore W2022387145C2776042228 @default.
- W2022387145 hasConceptScore W2022387145C2776178081 @default.
- W2022387145 hasConceptScore W2022387145C2776719499 @default.
- W2022387145 hasConceptScore W2022387145C2776780178 @default.
- W2022387145 hasConceptScore W2022387145C2776954882 @default.
- W2022387145 hasConceptScore W2022387145C2777394947 @default.
- W2022387145 hasConceptScore W2022387145C2777714996 @default.
- W2022387145 hasConceptScore W2022387145C2778024521 @default.
- W2022387145 hasConceptScore W2022387145C2779306644 @default.
- W2022387145 hasConceptScore W2022387145C2781018748 @default.
- W2022387145 hasConceptScore W2022387145C2908646376 @default.
- W2022387145 hasConceptScore W2022387145C2909548125 @default.
- W2022387145 hasConceptScore W2022387145C42219234 @default.
- W2022387145 hasConceptScore W2022387145C71924100 @default.
- W2022387145 hasIssue "8" @default.
- W2022387145 hasLocation W20223871451 @default.
- W2022387145 hasLocation W20223871452 @default.
- W2022387145 hasOpenAccess W2022387145 @default.
- W2022387145 hasPrimaryLocation W20223871451 @default.
- W2022387145 hasRelatedWork W2004483078 @default.
- W2022387145 hasRelatedWork W2019043549 @default.
- W2022387145 hasRelatedWork W2022387145 @default.
- W2022387145 hasRelatedWork W2037398109 @default.
- W2022387145 hasRelatedWork W2049002202 @default.
- W2022387145 hasRelatedWork W2087666617 @default.
- W2022387145 hasRelatedWork W2185203178 @default.
- W2022387145 hasRelatedWork W2386291963 @default.
- W2022387145 hasRelatedWork W9700541 @default.
- W2022387145 hasRelatedWork W2136449922 @default.
- W2022387145 hasVolume "92" @default.
- W2022387145 isParatext "false" @default.
- W2022387145 isRetracted "false" @default.
- W2022387145 magId "2022387145" @default.
- W2022387145 workType "article" @default.